These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36203429)

  • 1. Clinical analysis of deceased donor liver transplantation in the treatment of hepatocellular carcinoma with segmental portal vein tumor thrombus: A long-term real-world study.
    Sha M; Chen C; Shen C; Jeong S; Sun HY; Xu N; Hang HL; Cao J; Tong Y
    Front Oncol; 2022; 12():971532. PubMed ID: 36203429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical outcomes of patients with vascular invasion after deceased donor liver transplantation.
    Ye Z; Zhuang L; Liu X; Song M; Zhang J; Cao G
    J Gastrointest Oncol; 2024 Aug; 15(4):1686-1697. PubMed ID: 39279926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical outcomes of patients with portal vein tumor thrombi after living donor liver transplantation.
    Choi HJ; Kim DG; Na GH; Hong TH; Bae SH; You YK; Choi JY; Yoon SK
    Liver Transpl; 2017 Aug; 23(8):1023-1031. PubMed ID: 28480517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of deceased donor liver transplantation in hepatocellular carcinoma patients with portal vein tumor thrombus: A multicenter study.
    Yu J; Zhuang L; Liu P; Liu Z; Ling S; Deng Y; Li J; Yang B; Chen Z; Wang Z; Zang Y; Yang Y; Zheng S; Xu X
    Eur J Surg Oncol; 2022 Jan; 48(1):121-132. PubMed ID: 34456082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.
    Lv JY; Zhang NN; Du YW; Wu Y; Song TQ; Zhang YM; Qu Y; Liu YX; Gu J; Wang ZY; Qiu YB; Yang B; Tian DZ; Guo QJ; Zhang L; Sun JS; Xie Y; Wang ZL; Sun X; Jiang WT; Lu W
    Yonsei Med J; 2021 Jan; 62(1):29-40. PubMed ID: 33381932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-fetoprotein and
    Yang Z; Luo FZ; Wang S; Lerut J; Zhuang L; Li QY; Xu X; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):229-234. PubMed ID: 32303439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience With LDLT in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Postdownstaging.
    Soin AS; Bhangui P; Kataria T; Baijal SS; Piplani T; Gautam D; Choudhary NS; Thiagarajan S; Rastogi A; Saraf N; Saigal S
    Transplantation; 2020 Nov; 104(11):2334-2345. PubMed ID: 32032291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting bead transarterial chemoembolization as neoadjuvant therapy pre-liver transplantation for advanced-stage hepatocellular carcinoma.
    Ye ZD; Zhuang L; Song MC; Yang Z; Zhang W; Zhang JF; Cao GH
    World J Gastrointest Oncol; 2024 Jun; 16(6):2476-2486. PubMed ID: 38994164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term surgical outcomes of bile duct tumor thrombus versus portal vein tumor thrombus for hepatocellular carcinoma: a propensity score matching analysis.
    Li YN; Wei SM; Fu YK; Zeng ZX; Huang LM; Lv JH; Chen WZ; Wei YG; Zhang ZB; Zhou JY; Wu JY; Yan ML
    Front Oncol; 2024; 14():1372123. PubMed ID: 38628666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?
    Chen LP; Li C; Wen TF; Yan LN; Li B; Yang JY
    Pak J Med Sci; 2015; 31(4):763-9. PubMed ID: 26430399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation: would it be the best and last chance of cure for hepatocellular carcinoma with major venous invasion?
    Ma KW; Chan ACY; Chok KSH; She WH; Cheung TT; Dai WC; Fung JYY; Lo CM
    Hepatobiliary Surg Nutr; 2021 Jun; 10(3):308-314. PubMed ID: 34159158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombocytopenia: A prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy.
    Cheng YQ; Wang K; Zhang XP; Wei XB; Jiang YB; Hu YR; Mao FF; Guo WX; Shi J; Cheng SQ
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1214-1221. PubMed ID: 30402968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Preoperative Coagulability With Incidence and Extent of Portal Vein Tumor Thrombus and Survival Outcomes in Hepatocellular Carcinoma After Hepatectomy: A Large-Scale, Multicenter Study.
    Zhang XP; Zhou TF; Feng JK; Sun ZY; Zhen ZJ; Zhou D; Zhang F; Hu YR; Zhong CQ; Chen ZH; Chai ZT; Wang K; Shi J; Guo WX; Wu MC; Lau WY; Cheng SQ
    Front Oncol; 2021; 11():697073. PubMed ID: 34395264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of splenomegaly and splenectomy on prognosis in hepatocellular carcinoma with portal vein tumor thrombus treated with hepatectomy.
    Chai ZT; Zhang XP; Shao M; Ao JY; Chen ZH; Zhang F; Hu YR; Zhong CQ; Lin JH; Fang KP; Wu MC; Lau WY; Cheng SQ
    Ann Transl Med; 2021 Feb; 9(3):247. PubMed ID: 33708874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes of Liver Transplantation in Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Comparison with Portal Vein Tumor Thrombus.
    Lee JS; Kim J; Rhu J; Choi GS; Joh JW
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
    Yuan G; Cheng X; Li Q; Zang M; Huang W; Fan W; Wu T; Ruan J; Dai W; Yu W; Chen M; Guo Y; Hu X; Chen J
    Onco Targets Ther; 2020; 13():12683-12693. PubMed ID: 33328740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.
    Xiao GQ; Song JL; Shen S; Yang JY; Yan LN
    World J Gastroenterol; 2014 Aug; 20(31):10953-9. PubMed ID: 25152599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
    Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
    J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.
    Shi J; Lai EC; Li N; Guo WX; Xue J; Lau WY; Wu MC; Cheng SQ
    Ann Surg Oncol; 2010 Aug; 17(8):2073-80. PubMed ID: 20131013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.